Cargando…

Risk of subsequent atrial fibrillation in patients with myasthenia gravis: A population-based cohort study

The purpose of this study was to explore the association between myasthenia gravis (MG) and the risk of atrial fibrillation (AF) in an Asian population. The risk was analyzed in a cohort of 5528 patients with history of MG and 5528 individuals without MG using a hospitalization claim dataset. Both g...

Descripción completa

Detalles Bibliográficos
Autores principales: Liou, Yaw-Tzeng, Wei, James Cheng-Chung, Hu, Kai-Chieh, Hung, Yao-Min, Chou, Mei-Chia, Chang, Renin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137031/
https://www.ncbi.nlm.nih.gov/pubmed/34011098
http://dx.doi.org/10.1097/MD.0000000000026008
_version_ 1783695543847878656
author Liou, Yaw-Tzeng
Wei, James Cheng-Chung
Hu, Kai-Chieh
Hung, Yao-Min
Chou, Mei-Chia
Chang, Renin
author_facet Liou, Yaw-Tzeng
Wei, James Cheng-Chung
Hu, Kai-Chieh
Hung, Yao-Min
Chou, Mei-Chia
Chang, Renin
author_sort Liou, Yaw-Tzeng
collection PubMed
description The purpose of this study was to explore the association between myasthenia gravis (MG) and the risk of atrial fibrillation (AF) in an Asian population. The risk was analyzed in a cohort of 5528 patients with history of MG and 5528 individuals without MG using a hospitalization claim dataset. Both groups were matched by age, sex, index year and baseline comorbidities as an original analysis. A Cox proportional hazard model was used to estimate the hazard ratio and 95% confidence interval of AF after adjusting for demographic and relevant clinical covariates. The adjusted hazard ratio of the MG group compared with that of the non-MG group was 1.03 (95% confidence interval, 0.76–1.38) for AF. A stratified analysis showed that compared with the propensity score matched non-MG group, there was no increased risk of developing AF based on age categories, gender, or comorbidities. Different time follow-up periods results showed no increased risk of AF compared with the non-MG group. Overall, in the Taiwanese cohort, MG is not associated with an increased risk of AF.
format Online
Article
Text
id pubmed-8137031
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-81370312021-05-25 Risk of subsequent atrial fibrillation in patients with myasthenia gravis: A population-based cohort study Liou, Yaw-Tzeng Wei, James Cheng-Chung Hu, Kai-Chieh Hung, Yao-Min Chou, Mei-Chia Chang, Renin Medicine (Baltimore) 4400 The purpose of this study was to explore the association between myasthenia gravis (MG) and the risk of atrial fibrillation (AF) in an Asian population. The risk was analyzed in a cohort of 5528 patients with history of MG and 5528 individuals without MG using a hospitalization claim dataset. Both groups were matched by age, sex, index year and baseline comorbidities as an original analysis. A Cox proportional hazard model was used to estimate the hazard ratio and 95% confidence interval of AF after adjusting for demographic and relevant clinical covariates. The adjusted hazard ratio of the MG group compared with that of the non-MG group was 1.03 (95% confidence interval, 0.76–1.38) for AF. A stratified analysis showed that compared with the propensity score matched non-MG group, there was no increased risk of developing AF based on age categories, gender, or comorbidities. Different time follow-up periods results showed no increased risk of AF compared with the non-MG group. Overall, in the Taiwanese cohort, MG is not associated with an increased risk of AF. Lippincott Williams & Wilkins 2021-05-21 /pmc/articles/PMC8137031/ /pubmed/34011098 http://dx.doi.org/10.1097/MD.0000000000026008 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 4400
Liou, Yaw-Tzeng
Wei, James Cheng-Chung
Hu, Kai-Chieh
Hung, Yao-Min
Chou, Mei-Chia
Chang, Renin
Risk of subsequent atrial fibrillation in patients with myasthenia gravis: A population-based cohort study
title Risk of subsequent atrial fibrillation in patients with myasthenia gravis: A population-based cohort study
title_full Risk of subsequent atrial fibrillation in patients with myasthenia gravis: A population-based cohort study
title_fullStr Risk of subsequent atrial fibrillation in patients with myasthenia gravis: A population-based cohort study
title_full_unstemmed Risk of subsequent atrial fibrillation in patients with myasthenia gravis: A population-based cohort study
title_short Risk of subsequent atrial fibrillation in patients with myasthenia gravis: A population-based cohort study
title_sort risk of subsequent atrial fibrillation in patients with myasthenia gravis: a population-based cohort study
topic 4400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137031/
https://www.ncbi.nlm.nih.gov/pubmed/34011098
http://dx.doi.org/10.1097/MD.0000000000026008
work_keys_str_mv AT liouyawtzeng riskofsubsequentatrialfibrillationinpatientswithmyastheniagravisapopulationbasedcohortstudy
AT weijameschengchung riskofsubsequentatrialfibrillationinpatientswithmyastheniagravisapopulationbasedcohortstudy
AT hukaichieh riskofsubsequentatrialfibrillationinpatientswithmyastheniagravisapopulationbasedcohortstudy
AT hungyaomin riskofsubsequentatrialfibrillationinpatientswithmyastheniagravisapopulationbasedcohortstudy
AT choumeichia riskofsubsequentatrialfibrillationinpatientswithmyastheniagravisapopulationbasedcohortstudy
AT changrenin riskofsubsequentatrialfibrillationinpatientswithmyastheniagravisapopulationbasedcohortstudy